HBIO
NASDAQ · Life Sciences Tools & Services
Harvard Bioscience Inc
$7.98
+0.02 (+0.25%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+348.0% upside
Low Target
$24.20
Average Target
$35.75
High Target
$46.73
Current Price
$7.98
Current
$7.98
$7.98
Target
$35.75
$35.75
$24.20
$35.75 avg
$46.73
Scenario Analysis
Bear Case
$24.20
203.3%
Low target
Base Case
$35.75
+348.0%
Avg target
Bull Case
$46.73
+485.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$9.40
-15.1% from high
52-Week Low
$3.75
+112.8% from low
Target vs 52W High
$35.75
+280.3% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 36 | 81% | $369.21 | -45.6% |
| DHR | Strong Buy | 32 | 84% | $158.11 | -30.4% |
| A | Strong Buy | 30 | 77% | $64.69 | -63.1% |
| IQV | Strong Buy | 28 | 82% | $82.96 | -69.4% |
| WAT | Buy | 31 | 65% | $189.60 | -57.2% |
| ILMN | Buy | 28 | 57% | $169.36 | -37.7% |
| MTD | Hold | 19 | 53% | $170.43 | -89.0% |
| WST | Strong Buy | 23 | 91% | $136.24 | -63.7% |